12:00 AM
 | 
Apr 29, 2013
 |  BC Week In Review  |  Company News  |  Deals

AmorChem, Universit de Montreal deal

Life science VC fund AmorChem and the university's Univalor commercialization arm partnered to discover and develop drugs against abhydrolase domain containing 6 (ABHD6) to treat...

Read the full 113 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >